JP2015526444A5 - - Google Patents

Download PDF

Info

Publication number
JP2015526444A5
JP2015526444A5 JP2015527570A JP2015527570A JP2015526444A5 JP 2015526444 A5 JP2015526444 A5 JP 2015526444A5 JP 2015527570 A JP2015527570 A JP 2015527570A JP 2015527570 A JP2015527570 A JP 2015527570A JP 2015526444 A5 JP2015526444 A5 JP 2015526444A5
Authority
JP
Japan
Prior art keywords
chloro
trifluoromethyl
carboxylic acid
indazol
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015527570A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015526444A (ja
JP6204985B2 (ja
Filing date
Publication date
Priority claimed from PCT/CN2012/080139 external-priority patent/WO2014026330A1/en
Application filed filed Critical
Publication of JP2015526444A publication Critical patent/JP2015526444A/ja
Publication of JP2015526444A5 publication Critical patent/JP2015526444A5/ja
Application granted granted Critical
Publication of JP6204985B2 publication Critical patent/JP6204985B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015527570A 2012-08-15 2013-08-14 RORγT阻害剤としての3−アミノシクロアルキル化合物およびその使用 Expired - Fee Related JP6204985B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/CN2012/080139 WO2014026330A1 (en) 2012-08-15 2012-08-15 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
CNPCT/CN2012/080139 2012-08-15
PCT/US2013/054911 WO2014028600A2 (en) 2012-08-15 2013-08-14 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF

Publications (3)

Publication Number Publication Date
JP2015526444A JP2015526444A (ja) 2015-09-10
JP2015526444A5 true JP2015526444A5 (cg-RX-API-DMAC7.html) 2016-09-23
JP6204985B2 JP6204985B2 (ja) 2017-09-27

Family

ID=50101188

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015527570A Expired - Fee Related JP6204985B2 (ja) 2012-08-15 2013-08-14 RORγT阻害剤としての3−アミノシクロアルキル化合物およびその使用

Country Status (20)

Country Link
US (1) US9663522B2 (cg-RX-API-DMAC7.html)
EP (1) EP2920149B1 (cg-RX-API-DMAC7.html)
JP (1) JP6204985B2 (cg-RX-API-DMAC7.html)
KR (1) KR20150041660A (cg-RX-API-DMAC7.html)
CN (1) CN104822657A (cg-RX-API-DMAC7.html)
AU (1) AU2013302647A1 (cg-RX-API-DMAC7.html)
BR (1) BR112015003398A2 (cg-RX-API-DMAC7.html)
CA (1) CA2881699A1 (cg-RX-API-DMAC7.html)
CY (1) CY1122266T1 (cg-RX-API-DMAC7.html)
DK (1) DK2920149T3 (cg-RX-API-DMAC7.html)
ES (1) ES2742651T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20191001T1 (cg-RX-API-DMAC7.html)
HU (1) HUE044300T2 (cg-RX-API-DMAC7.html)
LT (1) LT2920149T (cg-RX-API-DMAC7.html)
PL (1) PL2920149T3 (cg-RX-API-DMAC7.html)
PT (1) PT2920149T (cg-RX-API-DMAC7.html)
RS (1) RS58892B1 (cg-RX-API-DMAC7.html)
RU (1) RU2015108933A (cg-RX-API-DMAC7.html)
SI (1) SI2920149T1 (cg-RX-API-DMAC7.html)
WO (2) WO2014026330A1 (cg-RX-API-DMAC7.html)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2487159A1 (en) 2011-02-11 2012-08-15 MSD Oss B.V. RorgammaT inhibitors
WO2014026327A1 (en) 2012-08-15 2014-02-20 Merck Sharp & Dohme Corp. 4-heteroaryl substituted benzoic acid compounds as rorgammat inhibitors and uses thereof
WO2014026328A1 (en) * 2012-08-15 2014-02-20 Merck Sharp & Dohme Corp. 3-cyclohexenyl substituted indole and indazole compounds as rorgammat inhibitors and uses thereof
WO2014026329A1 (en) 2012-08-15 2014-02-20 Merck Sharp & Dohme Corp. N-alkylated indole and indazole compounds as rorgammat inhibitors and uses thereof
DK3102576T3 (da) 2014-02-03 2019-07-22 Vitae Pharmaceuticals Llc Dihydropyrrolopyridininhibitorer af ror-gamma
AU2015222917A1 (en) 2014-02-27 2016-09-15 Lycera Corporation Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods
US20150252022A1 (en) * 2014-03-10 2015-09-10 Innov17 Llc Retinoic acid receptor-related orphan receptor modulators and uses thereof
EP3140291A4 (en) 2014-05-05 2018-01-10 Lycera Corporation Tetrahydroquinoline sulfonamide and related compounds for use as agonists of rory and the treatment of disease
WO2015171558A2 (en) 2014-05-05 2015-11-12 Lycera Corporation BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATEMENT OF DISEASE
US20160024057A1 (en) * 2014-07-25 2016-01-28 Innov17 Llc Indazole retinoic acid receptor-related orphan receptor modulators and uses thereof
SI3207043T1 (sl) 2014-10-14 2019-04-30 Vitae Pharmaceuticals, Inc. Dihidropirolopiridinovi inhibitorji za ROR-gama
GB201419015D0 (en) 2014-10-24 2014-12-10 Orca Pharmaceuticals Ltd Compounds
US9663515B2 (en) 2014-11-05 2017-05-30 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
US9845308B2 (en) 2014-11-05 2017-12-19 Vitae Pharmaceuticals, Inc. Isoindoline inhibitors of ROR-gamma
WO2016120850A1 (en) * 2015-01-30 2016-08-04 Pfizer Inc. Sulfonamide-subsituted indole modulators of rorc2 and methods of use thereof
CA2975997A1 (en) 2015-02-11 2016-08-18 Merck Sharp & Dohme Corp. Substituted pyrazole compounds as rorgammat inhibitors and uses thereof
WO2016128908A1 (en) * 2015-02-12 2016-08-18 Advinus Therapeutics Limited Bicyclic compounds, compositions and medicinal applications thereof
CN107614062A (zh) 2015-03-12 2018-01-19 加利福尼亚大学董事会 用RORγ抑制剂治疗癌症的方法
WO2016179343A1 (en) 2015-05-05 2016-11-10 Lycera Corporation DIHYDRO-2H-BENZO[b][1,4]OXAZINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE
CN107980042B (zh) 2015-06-11 2021-10-08 莱斯拉公司 用作RORγ激动剂和用于治疗疾病的芳基二氢-2H-苯并[b][1,4]噁嗪磺酰胺和相关化合物
EP3331876B1 (en) 2015-08-05 2020-10-07 Vitae Pharmaceuticals, LLC Modulators of ror-gamma
EP3368516B1 (en) 2015-10-27 2020-07-15 Merck Sharp & Dohme Corp. SUBSTITUTED BICYCLIC PYRAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
US10287272B2 (en) 2015-10-27 2019-05-14 Merck Sharp & Dohme Corp. Substituted indazole compounds as RORgammaT inhibitors and uses thereof
JP2018531958A (ja) 2015-10-27 2018-11-01 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. RORγT阻害薬としてのヘテロアリール置換安息香酸及びその使用
EP3868750A1 (en) 2015-11-20 2021-08-25 Vitae Pharmaceuticals, LLC Modulators of ror-gamma
TWI757266B (zh) 2016-01-29 2022-03-11 美商維它藥物有限責任公司 ROR-γ調節劑
US9481674B1 (en) 2016-06-10 2016-11-01 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
KR102615821B1 (ko) * 2017-04-11 2023-12-21 선샤인 레이크 파르마 컴퍼니 리미티드 불소-치환된 인다졸 화합물 및 이의 용도
WO2019018975A1 (en) 2017-07-24 2019-01-31 Vitae Pharmaceuticals, Inc. INHIBITORS OF ROR GAMMA
CN115716826A (zh) 2017-07-24 2023-02-28 生命医药有限责任公司 RORγ的抑制剂
CN107698493A (zh) * 2017-11-15 2018-02-16 上海皓伯化工科技有限公司 一种N‑Boc‑3‑哌啶酮的制备方法
CN111116590B (zh) * 2019-12-11 2021-07-06 广州医科大学 吲哚类化合物及其应用、制备方法
IL298928A (en) * 2020-06-30 2023-02-01 Dermira Inc RORγt INHIBITORS AND TOPICAL USES THEREOF
WO2022091048A1 (en) * 2020-10-30 2022-05-05 Integral Biosciences Private Limited Ectonucleotide pyrophosphatase-phosphodiesterase-1 (enpp1) inhibitors and uses thereof

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670447A (en) * 1983-08-22 1987-06-02 Hoechst-Roussel Pharmaceuticals Inc. Antipsychotic 3-(piperidinyl)- and 3-(pyrrolidinyl)-1H-indazoles
PT95899A (pt) 1989-11-17 1991-09-13 Glaxo Group Ltd Processo para a preparacao de derivados indole
US5532237A (en) * 1995-02-15 1996-07-02 Merck Frosst Canada, Inc. Indole derivatives with affinity for the cannabinoid receptor
US5639780A (en) 1995-05-22 1997-06-17 Merck Frosst Canada, Inc. N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors
US6133290A (en) * 1998-07-31 2000-10-17 Eli Lilly And Company 5-HT1F agonists
GB0117577D0 (en) * 2001-02-16 2001-09-12 Aventis Pharm Prod Inc Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D receptor ligands
US7355042B2 (en) * 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
JP2007516203A (ja) * 2003-07-09 2007-06-21 バイオリポックス エービー 炎症の治療に有用なインドール類
JP4525221B2 (ja) * 2004-07-16 2010-08-18 アステラス製薬株式会社 受容体リガンド同定法
GT200500208A (es) 2004-08-03 2006-03-02 Indazoles ùtiles para tratar enfermedades cardiovasculares
CN101048407A (zh) 2004-09-03 2007-10-03 普莱希科公司 双环杂芳基pde4b抑制剂
SE0402762D0 (sv) * 2004-11-11 2004-11-11 Astrazeneca Ab Indazole sulphonamide derivatives
CN100516049C (zh) 2004-11-16 2009-07-22 永信药品工业股份有限公司 抗血管生成药n2-(取代的芳基甲基)-3-(取代的苯基)吲唑的合成
EP1828180A4 (en) 2004-12-08 2010-09-15 Glaxosmithkline Llc 1H-pyrrolo [2,3-BETA] PYRIDINE
EP1984351A1 (en) * 2006-02-17 2008-10-29 Memory Pharmaceuticals Corporation Compounds having 5-ht6 receptor affinity
JP4675801B2 (ja) 2006-03-06 2011-04-27 日本メナード化粧品株式会社 Ror活性化剤
CN101437820A (zh) * 2006-03-07 2009-05-20 阿雷生物药品公司 杂二环吡唑化合物和使用方法
US7723330B2 (en) * 2006-03-07 2010-05-25 Array Biopharma Inc. Heterobicyclic pyrazole compounds and methods of use
GB0611587D0 (en) 2006-06-12 2006-07-19 Glaxo Group Ltd Novel compounds
MX2009011210A (es) * 2007-04-16 2009-10-30 Abbott Lab Inhibidores de mcl1 de indol 7-no sustituido.
GB0708141D0 (en) 2007-04-26 2007-06-06 Syngenta Participations Ag Improvements in or relating to organic compounds
AR067326A1 (es) 2007-05-11 2009-10-07 Novartis Ag Imidazopiridinas y pirrolo -pirimidinas sustituidas como inhibidores de cinasa de lipido
JP2010534665A (ja) 2007-07-25 2010-11-11 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング グルココルチコイドミメチックス、それらの製造方法、医薬組成物、及びこれらの使用
EP2181710A1 (en) 2008-10-28 2010-05-05 Phenex Pharmaceuticals AG Ligands for modulation of orphan receptor-gamma (NR1F3) activity
WO2010050837A1 (ru) 2008-10-28 2010-05-06 Haskin Lev Yakovlevich Ветроэнергетическая установка
CN102264743B (zh) 2008-11-25 2015-02-11 罗彻斯特大学 Mlk抑制剂及其使用方法
EP2408772B1 (en) * 2009-03-19 2015-07-01 Medical Research Council Technology Compounds
WO2010150837A1 (ja) 2009-06-25 2010-12-29 第一三共株式会社 インドリン誘導体
EP2459184A1 (en) 2009-07-31 2012-06-06 The Brigham and Women's Hospital, Inc. Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses
AU2010330894A1 (en) 2009-12-18 2012-07-05 Janssen Pharmaceutica Nv Substituted aminothiazolone indazoles as estrogen related receptor-aalpha modulators
US9260382B2 (en) * 2010-02-16 2016-02-16 Uwm Research Foundation Methods of reducing virulence in bacteria
GB201004311D0 (en) * 2010-03-15 2010-04-28 Proximagen Ltd New enzyme inhibitor compounds
EP2571361A4 (en) 2010-05-19 2013-11-13 Univ North Carolina PYRAZOLOPYRIMIDINE COMPOUNDS FOR CANCER TREATMENT
JP6063870B2 (ja) 2010-11-08 2017-01-18 ライセラ・コーポレイション RORγ活性の阻害用のN−スルホニル化テトラヒドロキノリンおよび関連二環化合物および病気の治療
KR20120063283A (ko) * 2010-12-07 2012-06-15 제일약품주식회사 신규한 피라졸로 피리딘 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 포함하는 약학적 조성물
WO2012085168A1 (en) 2010-12-22 2012-06-28 Ludwig-Maximilians-Universität München Organozinc complexes and processes for making and using the same
EP2487159A1 (en) 2011-02-11 2012-08-15 MSD Oss B.V. RorgammaT inhibitors
JP2014166961A (ja) 2011-06-20 2014-09-11 Dainippon Sumitomo Pharma Co Ltd 新規インダゾール誘導体
WO2014026327A1 (en) 2012-08-15 2014-02-20 Merck Sharp & Dohme Corp. 4-heteroaryl substituted benzoic acid compounds as rorgammat inhibitors and uses thereof
WO2014026329A1 (en) 2012-08-15 2014-02-20 Merck Sharp & Dohme Corp. N-alkylated indole and indazole compounds as rorgammat inhibitors and uses thereof
WO2014026328A1 (en) 2012-08-15 2014-02-20 Merck Sharp & Dohme Corp. 3-cyclohexenyl substituted indole and indazole compounds as rorgammat inhibitors and uses thereof

Similar Documents

Publication Publication Date Title
RU2015108933A (ru) 3-АМИНОЦИКЛОАЛКИЛЬНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ ROBгаммаT И ИХ ПРИМЕНЕНИЯ
JP2015526443A5 (cg-RX-API-DMAC7.html)
RU2015108898A (ru) 3-ЦИКЛОГЕКСЕНИЛ И ЦИКЛОГЕКСИЛ ЗАМЕЩЕННЫЕ ИНДОЛЬНЫЕ И ИНДАЗОЛЬНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ RORгаммаТ И ИХ ПРИМЕНЕНИЯ
JP2011527665A5 (cg-RX-API-DMAC7.html)
JP2017510555A5 (cg-RX-API-DMAC7.html)
JP2011527331A5 (cg-RX-API-DMAC7.html)
JP2012500277A5 (cg-RX-API-DMAC7.html)
HRP20170622T1 (hr) Derivati piridinila i kondenziranog piridinil triazolona
JP2012521994A5 (cg-RX-API-DMAC7.html)
JP2018522034A5 (cg-RX-API-DMAC7.html)
JP2018519323A5 (cg-RX-API-DMAC7.html)
JP2010526130A5 (cg-RX-API-DMAC7.html)
JP2015526441A5 (cg-RX-API-DMAC7.html)
EA201270751A1 (ru) Антагонист рецептора cgrp
RU2021133444A (ru) Производные бензимидазола в качестве модуляторов ror-гамма
JP2009530345A5 (cg-RX-API-DMAC7.html)
RS53075B (sr) Derivati 1,2,4-triazolo[4,3-a] piridina i njihova upotreba u tretmanu ili prevenciji neuroloških i psihijatrijskih poremećaja
JP2015501799A5 (cg-RX-API-DMAC7.html)
HRP20171670T1 (hr) Spojevi i sastavi za moduliranje egfr-aktiviteta
JP2018527295A5 (cg-RX-API-DMAC7.html)
IL256043A (en) nuclear receptor modulators
JP2010155827A5 (cg-RX-API-DMAC7.html)
JP2015509075A5 (cg-RX-API-DMAC7.html)
JP2012528137A5 (cg-RX-API-DMAC7.html)
JP2014133739A5 (cg-RX-API-DMAC7.html)